Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Change in Accrued Expenses (2010 - 2026)

Updated

Vistagen Therapeutics (VTGN) reported Change in Accrued Expenses of -$2.52 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with $3.2 million a year earlier.

Analysis

Vistagen Therapeutics (VTGN) Change in Accrued Expenses (2010 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics posted Change in Accrued Expenses of $828,000, down 85.4% from FY2025.

  • Change in Accrued Expenses has a five-year compound annual growth rate of 74.6% (FY2021 to FY2026).
  • By fiscal year, Change in Accrued Expenses came in at $5.68 million in FY2025 (+988.3%), $522,000 in FY2024, -$934,000 in FY2023 and $1.69 million in FY2022.
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Change in Accrued Expenses in data going back to fiscal Q1 2012.
  • Year over year, Change in Accrued Expenses gained in three of the last four quarters, with growth averaging 192.6%.
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -$53,000 (Q1 2027), -$243,000 (Q4 2026) and $294,000 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 397,968.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 2.41 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 983.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 756.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -2.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2.52 Mn
Jun 30, 2026 -53,000.00
Mar 31, 2026 -243,000.00
Dec 31, 2025 294,000.00
Sep 30, 2025 3.20 Mn
Jun 30, 2025 -2.42 Mn
Mar 31, 2025 2.96 Mn
Dec 31, 2024 1.98 Mn
Sep 30, 2024 1.20 Mn
Jun 30, 2024 -455,000.00
Mar 31, 2024 1.92 Mn
Dec 31, 2023 269,000.00
Sep 30, 2023 -450,000.00
Jun 30, 2023 -1.21 Mn
Mar 31, 2023 575,500.00
Dec 31, 2022 -1.46 Mn
Sep 30, 2022 -2.05 Mn
Jun 30, 2022 2.01 Mn
Mar 31, 2022 -488,400.00
Dec 31, 2021 -1.51 Mn
API Access

Vistagen Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY